Search Results - "Arecco L"

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.

Authors: Arecco, L. Bruzzone, M. Bas, R. et al.

Source: Annals of Oncology. Sep2024, Vol. 35 Issue 9, p792-804. 13p.

666MO Reliability of cerebrospinal fluid (CSF) ctDNA as a surrogate for tumor mutational profiling in central nervous system (CNS) metastases: Results from the BrainStorm (OncoDistinct006) study.

Authors: Arecco, L. Rothé, F. Venet, D. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS485-S486. 2p.

Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis.

Authors: Arecco, L Blondeaux, E Bruzzone, M et al.

Source: Human Reproduction. May2022, Vol. 37 Issue 5, p954-968. 15p.

243P Prognosis of patients with hormone receptor-positive/HER2-negative early breast cancer according to monarchE and NATALEE trials risk categories: Patient-level analysis of Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomised trials

Authors: Arecco, L. Blondeaux, E. Bruzzone, M. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS316-S316. 1p.

124 (PB-124) Poster - Adjuvant endocrine therapy choices in premenopausal patients with estrogen receptor-positive early breast cancer: insights from the GIM23-POSTER study.

Authors: Arecco, L. Latocca, M.M. Blondeaux, E. et al.

Source: European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.

83P Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in eary high risk breast cancer: The CITUCEL trial update.

Authors: Borea, R. Cardinali, B. Arecco, L. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS247-S247. 1p.

349P Body mass index (BMI) in postmenopausal patients (pts) with estrogen receptor (ER)-positive, HER2-negative early breast cancer (eBC): An exploratory analysis of LORELEI.

Authors: Dauccia, C. Franzoi, M.A. Saura Manich, C. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS348-S349. 2p.

2279MO Discontinuation and attrition rates in phase II or phase III first-line randomized clinical trials (RCTs) of solid tumors.

Authors: Blondeaux, E. Delucchi, V. Carmisciano, L. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1257-S1257. 1p.

LBA10 Primary endpoint results of the Neo-CheckRay phase II trial evaluating stereotactic body radiation therapy (SBRT) +/- durvalumab (durva) +/- oleclumab (ole) combined with neo-adjuvant chemotherapy (NACT) for early-stage, high risk ER+/HER2- breast cancer (BC)

Authors: De Caluwe, A. Desmoulins, I. Cao, K. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1205-S1205. 1p.

1141P Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma.

Authors: Croce, E. Boutros, A. Tanda, E.T. et al.

Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS684-S684. 1p.

1687P Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomized controlled trials: A systematic review and meta-analysis.

Authors: Boutros, A. Bruzzone, M. Tanda, E.T. et al.

Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS1180-S1181. 2p.

Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER⁺HER2^- breast cancer: a randomized phase 2 trial.

Authors: De Caluwé A Desmoulins I Cao K et al.

Source: Nature medicine [Nat Med] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Body mass index in postmenopausal women with estrogen receptor-positive, HER2-negative early breast cancer: An exploratory analysis of the LORELEI trial.

Authors: Dauccia C Franzoi MA Saura C et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 12; Vol. 244, pp. 116880. Date of Electronic Publication: 2026 Jun 12.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials.

Authors: Buonaiuto R Mangiacotti FP Giudici F et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2026 May 29; Vol. 88, pp. 104820. Date of Electronic Publication: 2026 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetant.

Authors: Pogoda K Arecco L Lambertini M

Source: Breast (Edinburgh, Scotland) [Breast] 2026 May 14; Vol. 88, pp. 104812. Date of Electronic Publication: 2026 May 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship.

Authors: Borea R Arecco L Nardin S et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Sep 17; Vol. 17, pp. 17588359251368733. Date of Electronic Publication: 2025 Sep 17 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis.

Authors: Perachino M Blondeaux E Molinelli C et al.

Source: European journal of clinical investigation [Eur J Clin Invest] 2025 Jun; Vol. 55 (6), pp. e70001. Date of Electronic Publication: 2025 Feb 13.

Publication Type: Journal Article; Systematic Review; Meta-Analysis

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362 (Electronic) Linking ISSN: 00142972 NLM ISO Abbreviation: Eur J Clin Invest Subsets: MEDLINE

Response to Venkataraman and Mokbel.

Authors: Arecco L Blondeaux E Agostinetto E et al.

Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2025 Jun 01; Vol. 117 (6), pp. 1289-1290.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE; In Process

Prognostic implications of risk definitions from the monarchE and NATALEE trials.

Authors: Arecco L Blondeaux E Bruzzone M et al.

Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2025 Jun 01; Vol. 117 (6), pp. 1198-1208.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis.

Authors: Arecco L Cacilhas PM Bobato Lara Gismondi C et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2026 Apr; Vol. 86, pp. 104719. Date of Electronic Publication: 2026 Feb 05.

Publication Type: Journal Article; Systematic Review; Meta-Analysis; Review

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE